Medtronic Reshapes Acute Care and Monitoring Business with Key Appointment

Medtronic, a leading medical technology company, has announced a significant leadership change in its acute care and monitoring business. The move comes as part of a broader restructuring effort within the company, signaling a renewed focus on innovation and growth in this crucial segment.
Jeb Denny Named Chief Medical Officer
Medtronic has appointed Jeb Denny as the new chief medical officer for its acute care and monitoring business. Denny, who began his role on Tuesday, brings a wealth of experience from his previous position as vice president of medical affairs for urology and critical care at BD. His expertise spans multiple areas, including smart connected care and vascular access devices.
Kate Benedict, president of acute care and monitoring at Medtronic, praised Denny's appointment, highlighting his "relentless dedication to putting patient needs first." She emphasized that Denny's expertise would be instrumental in accelerating Medtronic's innovation and growth strategies.
Strategic Realignment of Monitoring and Respiratory Businesses
This appointment follows a series of strategic decisions by Medtronic regarding its patient monitoring and respiratory interventions business. Initially, the company had planned to spin off this segment. However, in a significant shift last year, Medtronic opted to exit the ventilator market entirely and merge its remaining patient monitoring and respiratory businesses into a single unit.
The acute care and monitoring business, which encompasses pulse oximeters, patient monitors, and airway management tools, generated $1.9 billion in sales during Medtronic's 2025 fiscal year, ending in April. This consolidation and Denny's appointment are part of Medtronic's efforts to strengthen its position in this competitive market segment.
Implications for Medtronic's Future Direction
Denny's appointment represents more than just a personnel change; it signifies Medtronic's commitment to enhancing its medical leadership in acute care and monitoring. As a board-certified specialist in nephrology and internal medicine, Denny will continue to practice medicine alongside his corporate role, spending part of his time at the Physicians' Care Clinic in Decatur, Georgia.
This dual role underscores Medtronic's strategy of maintaining close connections with clinical practice, potentially fostering more patient-centric innovations and product development. As the medical technology landscape continues to evolve, Medtronic's latest moves suggest a proactive approach to addressing market challenges and capitalizing on new opportunities in acute care and patient monitoring.
References
- Medtronic names Jeb Denny as chief medical officer for acute care and monitoring
Denny leads the unit after Medtronic combined its patient monitoring and respiratory businesses last year.
Explore Further
What has been Medtronic's recent financial performance in the acute care and monitoring segment beyond the $1.9 billion in sales for fiscal year 2025?
What are Jeb Denny's main accomplishments in his prior roles that could influence Medtronic's innovation strategy?
What have been the trends in executive appointments or leadership changes among Medtronic's competitors in the acute care and monitoring market?
What specific factors led to Medtronic's decision to exit the ventilator market and restructure its patient monitoring and respiratory businesses?
How has Medtronic's approach to maintaining clinical practice connections among executives, like Jeb Denny, influenced its product development historically?